Liquidity ratios measure the company ability to meet its short-term obligations.
Paying user area
Try for free
DexCom Inc. pages available for free this week:
- Income Statement
 - Common-Size Income Statement
 - Common-Size Balance Sheet: Assets
 - Analysis of Profitability Ratios
 - Analysis of Long-term (Investment) Activity Ratios
 - Capital Asset Pricing Model (CAPM)
 - Selected Financial Data since 2005
 - Total Asset Turnover since 2005
 - Price to Sales (P/S) since 2005
 - Analysis of Debt
 
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to DexCom Inc. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Liquidity Ratios (Summary)
Based on: 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).
The financial liquidity indicators over the analyzed time frame reveal a noticeable downward trend in the company's short-term financial health.
- Current Ratio
 - The current ratio starts at a high level of 7.18 as of March 31, 2019, indicating a strong ability to cover current liabilities with current assets. Although there are fluctuations, the ratio maintains a generally high level above 5.0 through to December 31, 2021. Beginning in 2022, the ratio shows a marked decline, dropping significantly to 3.77 by September 30, 2022, and then experiencing a steep decrease to 1.99 by December 31, 2022. In the subsequent quarters, the ratio slightly recovers but remains relatively low at 2.8 as of September 30, 2023. This suggests a decreasing margin of safety in meeting short-term obligations.
 - Quick Ratio
 - The quick ratio trends mirror those of the current ratio but at slightly lower values, as expected since it excludes inventory. Initial values from March 31, 2019, start at 6.64, which represent strong liquidity levels. Stability is observed with minor fluctuations above 4.0 through the end of 2021. However, a decline commences in 2022, reaching a low of 3.26 in September 2022 and dropping sharply to 1.72 by December 31, 2022. Similar to the current ratio, this is followed by a gradual improvement, reaching 2.4 as of the last reported quarter. This pattern indicates a weakening in immediately liquid assets available to cover current liabilities during the recent periods.
 - Cash Ratio
 - The cash ratio, which measures the ability to cover current liabilities with cash and cash equivalents, starts at 5.77 as of March 31, 2019. It follows a slightly declining trend with minor fluctuations, retaining levels above 3.5 through most of 2021. From early 2022, a clear downward trajectory is evident, dropping sharply to 2.63 by September 30, 2022 and reaching the lowest point of 1.34 by December 31, 2022. Though there is some recovery thereafter, improving to 1.93 by September 30, 2023, the cash ratio remains substantially lower than its earlier high levels. This movement reflects a reduction in the company's most liquid assets over time.
 
Overall, the liquidity ratios indicate a strong liquidity position in the earlier years, followed by a persistent weakening trend starting in 2022. While some recovery is noted in the most recent quarters, the ratios have not returned to previous high levels. This pattern suggests growing constraints in the company's short-term financial flexibility which may warrant further attention to current asset management and liability structure to sustain operational stability.
Current Ratio
| Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||||||||||||||||||||
| Current assets | |||||||||||||||||||||||||
| Current liabilities | |||||||||||||||||||||||||
| Liquidity Ratio | |||||||||||||||||||||||||
| Current ratio1 | |||||||||||||||||||||||||
| Benchmarks | |||||||||||||||||||||||||
| Current Ratio, Competitors2 | |||||||||||||||||||||||||
| Abbott Laboratories | |||||||||||||||||||||||||
| Elevance Health Inc. | |||||||||||||||||||||||||
| Intuitive Surgical Inc. | |||||||||||||||||||||||||
| Medtronic PLC | |||||||||||||||||||||||||
| UnitedHealth Group Inc. | |||||||||||||||||||||||||
Based on: 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).
1 Q3 2023 Calculation
            Current ratio = Current assets ÷ Current liabilities
            =  ÷  = 
2 Click competitor name to see calculations.
The analysis of the quarterly financial data reveals notable fluctuations and trends in current assets, current liabilities, and the current ratio over the observed periods.
- Current Assets
 - Current assets demonstrated a general upward trajectory from March 2019 through June 2023. Beginning at approximately 1,690,800 thousand USD in March 2019, there was steady growth reaching a peak of around 5,002,900 thousand USD by June 2023. This increase indicates substantial asset accumulation with occasional periods of slower growth or slight declines, such as in the third quarter of 2022.
 - Current Liabilities
 - Current liabilities also increased significantly but with more volatility compared to current assets. Starting from 235,400 thousand USD in March 2019, liabilities rose consistently with some sharper jumps observed in late 2022 and into 2023, reaching a high of approximately 2,069,700 thousand USD by September 2023. The peak in liabilities around December 2022 suggests a potential increase in short-term obligations or operational costs during that period.
 - Current Ratio
 - The current ratio exhibited a marked decline over the timeline, moving from a very strong liquidity position of 7.18 in March 2019 to a significantly lower value of 2.80 by September 2023. Initially, the ratio fluctuated between approximately 5 and 7, indicating robust ability to cover short-term liabilities with current assets. However, the ratio dropped sharply in late 2022 to values below 4, reflecting rising current liabilities outpacing the growth of current assets during this time. Although there is some recovery in 2023, the current ratio remains significantly lower than earlier periods, pointing to a tightening liquidity position.
 
Overall, the financial data indicate that while the company has increased its current assets substantially over the period, the growth in current liabilities has been more pronounced in recent quarters. This trend is highlighted by the declining current ratio, which suggests increasing pressure on short-term liquidity despite the asset growth. The sharper increases in liabilities in late 2022 and continued into 2023 warrant close monitoring to ensure sustainable management of working capital and financial stability.
Quick Ratio
| Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||||||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||||||||||
| Short-term marketable securities | |||||||||||||||||||||||||
| Accounts receivable, net | |||||||||||||||||||||||||
| Total quick assets | |||||||||||||||||||||||||
| Current liabilities | |||||||||||||||||||||||||
| Liquidity Ratio | |||||||||||||||||||||||||
| Quick ratio1 | |||||||||||||||||||||||||
| Benchmarks | |||||||||||||||||||||||||
| Quick Ratio, Competitors2 | |||||||||||||||||||||||||
| Abbott Laboratories | |||||||||||||||||||||||||
| Elevance Health Inc. | |||||||||||||||||||||||||
| Intuitive Surgical Inc. | |||||||||||||||||||||||||
| Medtronic PLC | |||||||||||||||||||||||||
| UnitedHealth Group Inc. | |||||||||||||||||||||||||
Based on: 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).
1 Q3 2023 Calculation
            Quick ratio = Total quick assets ÷ Current liabilities
            =  ÷  = 
2 Click competitor name to see calculations.
The analysis of the quarterly financial indicators reveals significant fluctuations in the liquidity position over the observed periods. The total quick assets exhibited a general upward trend from early 2019 through mid-2023, with notable peaks and subsequent declines. Initially, quick assets increased moderately from approximately $1.56 billion to over $3.2 billion by late 2021, demonstrating an accumulation of highly liquid resources. Following that period, the quick assets experienced volatility, peaking sharply to around $4.39 billion in mid-2023 before experiencing a decrease.
Concomitantly, current liabilities portrayed an increasing trajectory with notable surges in certain quarters. Starting from $235.4 million in early 2019, the liabilities grew steadily, reaching a peak of approximately $1.87 billion in the third quarter of 2023. This substantial rise in current liabilities, particularly marked from 2022 onwards, suggests an increasing short-term financial obligation burden.
The quick ratio, reflecting the company’s ability to cover its short-term liabilities with its most liquid assets, showed a declining trend throughout the periods. From a high of 6.64 in the first quarter of 2019, this ratio decreased sharply over the years, indicating a decreasing liquidity buffer relative to current liabilities. There was a notable decline starting in 2022, with the quick ratio dropping below 4 and further decreasing to approximately 2.4 by the third quarter of 2023, signaling a reduced margin of safety.
Overall, these trends indicate that while the total quick assets have generally increased, the pace of growth in current liabilities has outstripped asset liquidity growth in recent periods. The declining quick ratio corresponds to increased liquidity risk, suggesting the company may be facing tighter short-term financial conditions. Monitoring of liabilities management and liquidity maintenance will be critical in upcoming periods to ensure financial stability.
Cash Ratio
| Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||||||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||||||||||
| Short-term marketable securities | |||||||||||||||||||||||||
| Total cash assets | |||||||||||||||||||||||||
| Current liabilities | |||||||||||||||||||||||||
| Liquidity Ratio | |||||||||||||||||||||||||
| Cash ratio1 | |||||||||||||||||||||||||
| Benchmarks | |||||||||||||||||||||||||
| Cash Ratio, Competitors2 | |||||||||||||||||||||||||
| Abbott Laboratories | |||||||||||||||||||||||||
| Elevance Health Inc. | |||||||||||||||||||||||||
| Intuitive Surgical Inc. | |||||||||||||||||||||||||
| Medtronic PLC | |||||||||||||||||||||||||
| UnitedHealth Group Inc. | |||||||||||||||||||||||||
Based on: 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).
1 Q3 2023 Calculation
            Cash ratio = Total cash assets ÷ Current liabilities
            =  ÷  = 
2 Click competitor name to see calculations.
The analysis of the quarterly financial data reveals several notable trends in the company's liquidity and short-term financial obligations over the observed periods.
- Total Cash Assets
 - The total cash assets demonstrate a general upward trend from March 31, 2019, through June 30, 2020, increasing significantly from approximately $1.36 billion to over $2.5 billion. This growth continues, with some fluctuations, until the first quarter of 2023 where cash assets peak at approximately $3.64 billion on June 30, 2023. Following this peak, there is a moderate decline but cash levels remain substantially higher than the earlier periods, suggesting improved cash reserves over time.
 - Current Liabilities
 - Current liabilities show a steady increase from March 31, 2019, through December 31, 2022, rising from about $235 million to nearly $1.84 billion in June 2023. There is a significant surge in liabilities starting around December 31, 2022, which more than doubles the liabilities compared to the previous period, indicating a sharp increase in short-term obligations during this timeframe. This may reflect increased operational expenses, financing activities, or other liabilities maturing in the short term.
 - Cash Ratio
 - The cash ratio, which measures the company's ability to cover its current liabilities with cash and cash equivalents, declines significantly over the period. Starting at a very strong position of 5.77 in March 2019, this ratio gradually decreases with some fluctuations and drops sharply after December 31, 2022, reaching its lowest point of 1.34 by March 31, 2023. Although there is a slight recovery toward September 30, 2023, the ratio remains considerably lower than earlier levels. This reduction indicates a weakening in liquidity relative to current liabilities, suggesting increased risk in meeting short-term obligations solely with cash.
 
In summary, while the company's total cash assets have generally increased substantially during the period, the concurrent sharp rise in current liabilities has led to a pronounced decline in the cash ratio. This divergence highlights a shift toward higher short-term liabilities that outpace cash growth, pointing to potential liquidity pressure or strategic changes in working capital management. Close monitoring of this trend is advisable to assess liquidity risk and the company’s ability to meet immediate financial obligations.